These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Low to intermediate grade salivary duct carcinoma associated with osteoclast like-giant cell tumor of parotid gland: a rare case with distinct pathological features. Pasricha S; Gandhi JS; Mehta A; Gupta G; Pradhan T J Cancer Res Ther; 2013; 9(2):314-6. PubMed ID: 23771386 [TBL] [Abstract][Full Text] [Related]
7. Sarcomatoid variant of salivary duct carcinoma: clinicopathologic and immunohistochemical study of eight cases with review of the literature. Nagao T; Gaffey TA; Serizawa H; Iwaya K; Watanabe A; Yoshida T; Yamazaki K; Sageshima M; Lewis JE Am J Clin Pathol; 2004 Aug; 122(2):222-31. PubMed ID: 15323139 [TBL] [Abstract][Full Text] [Related]
8. Salivary duct carcinoma: what is already known, and can we improve survival? Wee DT; Thomas AA; Bradley PJ J Laryngol Otol; 2012 Jul; 126 Suppl 2():S2-7. PubMed ID: 22495125 [TBL] [Abstract][Full Text] [Related]
10. Salivary Duct Carcinoma: An Update on Morphologic Mimics and Diagnostic Use of Androgen Receptor Immunohistochemistry. Udager AM; Chiosea SI Head Neck Pathol; 2017 Sep; 11(3):288-294. PubMed ID: 28321773 [TBL] [Abstract][Full Text] [Related]
11. [Salivary duct carcinoma of the sublingual gland--a case report]. Sartorius C; Gille F; Bédrossian-Pfingsten J; Kempf HG Laryngorhinootologie; 2006 Jul; 85(7):517-9. PubMed ID: 16586279 [TBL] [Abstract][Full Text] [Related]
12. Salivary-duct carcinoma (SDC): A rare case report. Li Z; Zhou Q; Wang Y; Li G Asian J Surg; 2024 May; 47(5):2441-2442. PubMed ID: 38302356 [No Abstract] [Full Text] [Related]
14. Salivary duct carcinoma with rhabdoid features: a salivary counterpart of pleomorphic lobular carcinoma of the breast. Kusafuka K; Kawasaki T; Maeda M; Yamanegi K; Baba S; Ito Y; Inagaki H; Nakajima T Histopathology; 2017 Jan; 70(2):164-173. PubMed ID: 27079821 [TBL] [Abstract][Full Text] [Related]
15. Androgen receptor-positive salivary duct carcinoma: a disease entity with promising new treatment options. Jaspers HC; Verbist BM; Schoffelen R; Mattijssen V; Slootweg PJ; van der Graaf WT; van Herpen CM J Clin Oncol; 2011 Jun; 29(16):e473-6. PubMed ID: 21422415 [No Abstract] [Full Text] [Related]
16. Salivary duct carcinoma of the larynx: report of a rare case. Goel MM; Agrawal SP; Srivastava AN Ear Nose Throat J; 2003 May; 82(5):371-3. PubMed ID: 12789763 [TBL] [Abstract][Full Text] [Related]
18. Exploring the potential of circulating tumour DNA to monitor treatment response in salivary duct carcinoma patients of the CABO-ASAP trial. Weijers JAM; de Bitter TJJ; Verhaegh GW; van Boxtel W; Uijen MJM; van Engen-van Grunsven ACH; Driessen CML; Schalken JA; Ligtenberg MJL; van Herpen CML Oral Oncol; 2023 Dec; 147():106620. PubMed ID: 37939426 [No Abstract] [Full Text] [Related]
19. Clinical and immunohistologic typing of salivary duct carcinoma: a report of 50 cases. Jaehne M; Roeser K; Jaekel T; Schepers JD; Albert N; Löning T Cancer; 2005 Jun; 103(12):2526-33. PubMed ID: 15900577 [TBL] [Abstract][Full Text] [Related]
20. Anti-PD-1 plus anti-HER2 and chemotherapy showed superior and durable clinical benefit in a patient with advanced salivary duct carcinoma. Ma P; Shen HY; Chen DS; Lu ZY; Gao W; Shu YQ Oral Oncol; 2022 Jul; 130():105905. PubMed ID: 35594774 [No Abstract] [Full Text] [Related] [Next] [New Search]